CARsgen Therapeutics Holdings Limited (HKG:2171)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.20
+0.14 (0.73%)
Jun 6, 2025, 4:08 PM HKT
193.13%
Market Cap 10.57B
Revenue (ttm) 41.95M
Net Income (ttm) -849.35M
Shares Out 550.40M
EPS (ttm) -1.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,017,060
Average Volume 3,247,906
Open 19.26
Previous Close 19.06
Day's Range 18.38 - 19.26
52-Week Range 2.48 - 23.90
Beta 0.48
RSI 51.56
Earnings Date May 28, 2025

About HKG:2171

CARsgen Therapeutics Holdings Limited, an investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United States. Its products include CT053 for the treatment of relapsed/refractory multiple myeloma. The company is also developing autologous CAR-T product candidates, including CT041, which targets Claudin 18.2, is in phase II/III clinical trial for gastric/gastroesophageal junction cance... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 465
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2171
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.